G Gorchev

Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors

Günter Emons, Manfred Kaufmann, G Gorchev et al. · Gynecologic Oncology · 2010 · 58 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Efficacy and Safety of AEZS-108 (LHRH Agonist Linked to Doxorubicin) in Women With Advanced or Recurrent Endometrial Cancer Expressing LHRH Receptors

G Gorchev, Philipp Harter, Pauline Wimberger et al. · International Journal of Gynecological Cancer · 2014 · 56 citations · Full text

Medicine, Oncology, Pharmacology +14

Efficacy and safety of AEZS-108 (INN: Zoptarelin Doxorubicin Acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: A multicenter Phase II trial of the ago-study group (AGO GYN 5)

Günter Emons, G Gorchev, Jalid Sehouli et al. · Gynecologic Oncology · 2014 · 50 citations

Medicine, Oncology, Pharmacology +17

Improving quality of life in pancreatic cancer patients following high-intensity focused ultrasound (HIFU) in two European centers

Milka Marinova, Hyuliya Feradova, Maria A. González-Carmona et al. · European Radiology · 2021 · 34 citations

Medicine, Oncology, Surgery +13

Peri-operative and survival outcomes analysis of patients with endometrial cancer managed by three surgical approaches: a long-term Bulgarian experience

G Gorchev, Desislava K. Kiprova, Aleksandar D. Lyubenov et al. · Journal of Robotic Surgery · 2022 · 11 citations

Medicine, Gynecology, Surgery +8